Pura Vida Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Pura Vida Investments’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52,213	Closed	-$1.95M	–	320
2021 Q3	$1.95M	Buy	+52,213	New	+$1.82M	0.06%	190
2020 Q4	–	Sell	-150,000	Closed	-$3.85M	–	224
2020 Q3	$3.85M	Buy	+150,000	New	+$3.42M	0.2%	100
2019 Q4	–	Sell	-109,130	Closed	-$815K	–	126
2019 Q3	$815K	Buy	+109,130	New	+$1.05M	0.14%	84
2019 Q2	–	Sell	-100,000	Closed	-$1.28M	–	129
2019 Q1	$1.22M	Buy	+100,000	New	+$1.28M	0.17%	89
2018 Q3	–	Sell	-20,000	Closed	-$418K	–	136
2018 Q2	$353K	Buy	+20,000	New	+$406K	0.14%	89

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Pura Vida Investments's ITCI Position: Q4 2021 in Review

Pura Vida Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2021, closing a stake of 52,213 shares — an estimated $1.95M sold.

Pura Vida Investments first reported a position in ITCI in Q2 2018 and held it in 5 quarters. The position peaked at $3.85M in Q3 2020. 208 funds tracked by Wall St. Rank hold ITCI as of Q4 2021.

Pura Vida Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2021 after selling out during the quarter.
Pura Vida Investments sold 52,213 Intra-Cellular Therapies Inc. shares in Q4 2021, an estimated $1.95M.
Pura Vida Investments first reported a position in Intra-Cellular Therapies Inc. in Q2 2018 and held it in 5 quarters.
Pura Vida Investments's Intra-Cellular Therapies Inc. position peaked at $3.85M in Q3 2020.
208 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.